PUBLISHER: TechNavio | PRODUCT CODE: 1719499
PUBLISHER: TechNavio | PRODUCT CODE: 1719499
The in vitro diagnostics (IVD) contract manufacturing market is forecasted to grow by USD 12966.6 mn during 2024-2029, accelerating at a CAGR of 13.1% during the forecast period. The report on the in vitro diagnostics (IVD) contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for one-stop-shop ivd contract manufacturing, increasing prevalence of chronic and infectious diseases and rising geriatric population, and high growth potential for market in emerging countries.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 11.3% |
CAGR | 13.1% |
Incremental Value | $12966.6 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's in vitro diagnostics (IVD) contract manufacturing market is segmented as below:
By Device
By Service Type
By Technology
By Geographical Landscape
This study identifies the leasing of ivd equipment as one of the prime reasons driving the in vitro diagnostics (IVD) contract manufacturing market growth during the next few years. Also, growing adoption of partnerships and acquisitions by market companies and favorable reduction in operational and capital expenditure of ivd will lead to sizable demand in the market.
The report on the in vitro diagnostics (IVD) contract manufacturing market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in vitro diagnostics (IVD) contract manufacturing market vendors that include Argonaut Manufacturing Services Inc., Avioq Inc, Bio Techne Corp., CorDx, Genemed Biotechnologies Inc., HDA Technology Inc., HU Group Holdings Inc., Invetech, Jena Bioscience GmbH, JSR Corp., Merck KGaA, More Diagnostics Inc., Neogen Corp., PHC Holdings Corp., Prestige Diagnostics UK Ltd., Seyonic SA, TCS Biosciences Ltd., TE Connectivity Ltd., Thermo Fisher Scientific Inc., and Veracyte Inc.. Also, the in vitro diagnostics (IVD) contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: